Datum: 07.12.2017
Autor: Lauren
Very Good Site mycelex-g online Analysts at Cowen and Co initiated coverage of thebiotechnology company with an "outperform" rating, saying thecompany's experimental anticoagulant REG1 could be moreeffective than bivalirudin, a competing drug sold by TheMedicine Co under the brand name Angiomax.